Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI could revolutionize bleeding stroke diagnosis and prognosis

NCT ID NCT07570680

Knowledge-focused Sponsor: Second Affiliated Hospital of Nanchang University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to create an artificial intelligence (AI) model to help doctors diagnose and predict recovery for people with a bleeding stroke (spontaneous intracerebral hemorrhage). The researchers will use brain scans and other data from 7,100 patients to train the AI. The goal is to improve accuracy and consistency in diagnosis and better predict outcomes like survival and independence after 90 and 180 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 7,100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2022

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Spontaneous hemorrhagic stroke, including parenchymal hemorrhage, subarachnoid hemorrhage, intraventricular hemorrhage, and subdural hemorrhage(including chronic subdural hemorrhage).

Ages

8 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age \>= 8 years old; 2. Patients diagnosed with spontaneous hemorrhagic stroke based on medical history and auxiliary examinations; 3. Received non-contrast computed tomography (NCCT) in the outpatient or emergency department; 4. Treated in accordance with standard clinical guidelines during hospitalization; 5. Have complete clinical data. Exclusion Criteria: 1. Had undergone surgical treatment in another hospital before admission; 2. Was in a state of shock upon admission; 3. Had severe heart, liver, or kidney dysfunction or other life-threatening systemic diseases; 4. Died during hospitalization; 5. Had an expected lifespan of less than six months or was unable to complete the study follow-up for other reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemorrhage stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemorrhagic stroke intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemorrhage stroke

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Second Affiliated Hospital of Nanchang University

    RECRUITING

    Nanchang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.